NeuroLF is not yet commercially available. Regulatory approval is expected in 2024 in Europe and the US. Follow us on Linkedin to stay up to date.

NeuroLF is used by trained clinicians to diagnose brain related disorders. The initial application is for the diagnosis of Alzheimer’s disease. You can learn more about it here.

Please complete the contact form to get in touch with one of our representatives. We are happy to discuss with you options that meet your needs best.